In the cancer context, Jin and colleagues have shown that endocan overexpression correlated with increased breast cancer cell proliferation and migration due to enhanced ERK 1/2 activity; they also found that the degree of ERK1/2 activation was strongly reduced in cells where the expression of endocan was inhibited. This evidence concerns the gene ESM1 and breast cancer.